M. Sakkal - Dermatology, Gustave Roussy - Cancer Campus

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1024P Initial Clinical Results of BT-001, an Oncolytic Virus Expressing an Anti-Ctla4 Mab, Administered As Single Agent and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors

S. Champiat,C. Lebbe,J-F. Baurain,A. Italiano,M. Sakkal, C. Spring-Giusti,N. Stojkowitz, M. Brandely, A. Sadoun, A. Ropenga, M. Semmrich, A. McAllister,M. Chisamore,P. Cassier

Annals of Oncology（2024）

引用0浏览0引用

1177P FRESH: the Gustave Roussy Program to Facilitate Access to Liquid Biopsy for Precision Oncology in France

E. Rouleau,M. Morfouace, S. Taleb,M. Sakkal,M. Aldea,A. Hollebecque,B. Verret, V. Suybeng,A. Bayle,L. Lacroix,S. Michiels, E. Angevin,F. André,B. Besse,C.P. Massard,F. Barlesi,A. Italiano

Annals of Oncology (2024): S764

引用0浏览0引用

142P Exploring 18F-FDG PET As a Predictior of Immune-Related Adverse Events (iraes) in Early-Stage Triple-Negative Breast Cancer (Etnbc)

A.L. Daverio,F. Giugliano, J.R. Dixon Douglas, L.W. Rached,A. Laparra,M. Sakkal,C. Bousrih,A.A. Viansone,S. Delaloge,B. Pistilli, D. Deandreis, J.T.L. Ribeiro Mourato, T. Henry

ESMO Open（2024）

引用0浏览0引用

Real-world Safety and Effectiveness of Neoadjuvant Chemotherapy Combination with Pembrolizumab in Triple-Negative Breast Cancer

L. Rached, F. Peyre-Pradat, M. Spotti,C. Baldini,A. Laparra,O. Lambotte,M. Sakkal,A. Perret,A. Viansone,S. Michiels,S. Delaloge,B. Pistilli, J.M. Ribeiro

ESMO Real World Data and Digital Oncology (2024): 100061

引用0浏览0引用

Extending Baseline 18F-FDG PET/CT Clinical Relevance in Early Stage Triple Negative Breast Cancer (Etnbc)

A. Daverio, F. Giugliano, J. Dixon-Douglas, L. Rached,A. Laparra,M. Sakkal,C. Bousrih,A. Viansone,S. Morbelli, S. Delaloge, B. Pistilli,D. Deandreis, J. M. Ribeiro,T. Henry

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2024): S491-S492

引用0浏览0引用

80P Tumor Markers Evolution in Pts Treated with TCE and Association with Radiologic Response

C. d'Abrigeon,K. Ouali, N. Herbel,S. Champiat,A. Hollebecque,C. Smolenschi,M. Sakkal,R. Bahleda,A. Gazzah,A. Patrikidou,J-M. Michot, T. Hueso,S. Ammari,Y. Loriot,C.P. Massard,A. Bernard-Tessier, M. Texier,C. Baldini

Immuno-Oncology and Technology (2024): 100823

引用0浏览0引用

Safety and Efficacy of Antibody Drug Conjugates in Older Patients with Solid Tumors

A. Vaz Ferreira,M. Frelaut,A. Pagès,A. Hollebecque,A. Gazzah,R. Bahleda,J.M. Michot,F.X. Danlos,L. Seknazi,V. Goldschmidt,C. Hénon,M. Sakkal,C. Smolenschi,S. Champiat,A. Marabelle,Y. Loriot, C. Lazarovici-Nagera, Z. Ap-Thomas, G. Beraud Chaullet,K. Ouali

Journal of Geriatric Oncologyno. 8 (2023): S12

引用0浏览0引用

Impact Thérapeutique Du Profilage Moléculaire Des Patients Atteints De Mélanome Résistant Au Traitement Standard : Résultats « En Vie Réelle »

M. Sakkal,M. Aldea,A. Bayle,D. Vasseur,E. Routier,S. Roy,A. Gazzah,C. Smolenschi,R. Bahleda,C. Baldini,S. Champiat,Y. Loriot,L. Lacroix,E. Rouleau,A. Hollebecque,A. Italiano,S. Ponce-Aix,C. Robert

Annales de Dermatologie et de Vénéréologie - FMCno. 8 (2023): A174

引用0浏览0引用

1161P Therapeutic Outcome of Molecular Profiling of Melanoma Patients Resistant to Standard Treatment: Real-world Data

M. Sakkal,M. Aldea,A. Bayle,D. Vasseur,E. Routier,D. Belkadi-Sadou,A. Marchand,A. Gazzah,C. Smolenschi,R. Bahleda,C. Baldini,S. Champiat,Y. Loriot,L. Lacroix,E. Rouleau,A. Hollebecque,A. Italiano,S. Ponce Aix,C. Robert

ANNALS OF ONCOLOGY (2023): S692-S692

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn